Navigation Links
EpiCept Corporation to Present New NP-1 Data at American Pain,Society Meeting

and expand upon earlier work which provided an efficacy signal in this type of neuropathic pain. The primary endpoint for this trial is the change in pain intensity over the four week duration of the trial.

The second trial is a 500 patient, placebo- and active-controlled trial in PHN. This trial will compare the efficacy and safety of NP-1 vs. gabapentin as well as placebo. This active comparator trial is one of the first such efforts to examine any candidate compound at this scale in neuropathic pain. The primary endpoint for this trial is the change in pain intensity over the four week duration of the trial.

EpiCept's Approach to Treating Pain

EpiCept's pain product candidates are designed to topically deliver FDA- approved pain management therapeutics directly to the surface of the skin, thereby blocking the ability of peripheral nerve receptors to transmit pain messages to the brain, providing significant pain relief, with fewer adverse side effects, fewer drug to drug interactions and lower potential for abuse than systemically delivered analgesics.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. EpiCept has a staged portfolio of pharmaceutical product candidates with several pain therapies in late-stage clinical trials, and a lead oncology compound (for acute myeloid leukemia, or AML) with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound has been submitted in Europe. EpiCept is based in Tarrytown, N.Y., and its research and development team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements incl
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
2. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
4. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
5. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
6. The Past, Present and Future of HLA Typing
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
Post Your Comments:
(Date:10/7/2008)...alif., Oct. 7 /- Aerovance Inc. today...m a Phase I trial of its Aerovant,inhalation powde...nce of,local irritancy following asthma patients, ...se will be the highest of three doses investigated...h is scheduled to begin early,next year. Evidence ...
(Date:10/7/2008)...panded to Eight On-Demand Tests for Use on the Gen... SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ ...ase of Xpert(TM) vanA/vanB as a European CE,IVD Ma...o Diagnostic,Medical Devices. The test delivers ra... most commonly associated with vancomycin-resistan...
(Date:10/6/2008).... 6 /PRNewswire-USNewswire/ -- "A return to the us...lopment is without scientific,justification," acco...ernatives to Laboratory Animals (ATLA). "An Assess...search" concludes that vaccine responses in,chimpa...nd that claims of,chimpanzees, critical role and i...
(Date:10/6/2008)...ss Promising Research at The American College of N...g, WASHINGTON, Oct. 6 /- New researc...niors was presented at The American College of,Nut...ical Applications of,Probiotics in Health and Dise...cs, aging, and nutrition discussed the potential u...
Breaking Medicine Technology:Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Bushs Budget Proposal Would Cut Medicare Funding 10974 1Bushs Budget Proposal Would Cut Medicare Funding 10974 2Bushs Budget Proposal Would Cut Medicare Funding 10974 3Bushs Budget Proposal Would Cut Medicare Funding 10974 4Over 300 Children Are Given New Smiles 10972 1Over 300 Children Are Given New Smiles 10972 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 1Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 3Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 1Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 2
...YTON, Ohio, June 08, 2007,/PRNewswire-FirstCall/ -...tic Fibrosis Society Annual,Meeting. ..., -- Exocrine pancreatic insufficiency (EPI) is...lly produced by,the pancreas that can result from ...ibrosis, chronic pancreatitis, and , , pancr...
... Patients Taking Trexima were Migraine Free,Compar... -- New data from two large,trials show that Trexi...e as placebo in eliminating all traditional migrai...attacks with just,one tablet. The findings will be...Meeting of the American Headache Society. , In add...
Other Medicine Technology:Eurand to Present Zentase Phase III Data 2Eurand to Present Zentase Phase III Data 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 4
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...You might call this a professional car wash salon ...ane has a sexy lady at the wheel, going swish swas... And if thats not enough to give the lady (your c... choose a nude lady car washer to strip your car o...
...Transformational contribution to support new clini...n Johns Hopkins officials today announced a signif...ne from His Highness Sheikh Khalifa bin Zayed Al ... (UAE). Most of the gift, made in honor of Sheikh ...
...The link between environmental exposures and asthm... researchers at the Harvard School of Public Healt...ic violence and asthma. The study, in the upcomin...emiology, raises questions about the role of stres...
...More research is needed to determine the true effe...developing fetus, and the impact on pregnant women...pregnancy, child health researchers say. Recomme... during pregnancy vary across English-speaking cou...
Other Medicine News:Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 3Health News:Research Demonstrates Link Between Domestic Violence and Asthma 2Health News:Better Research Needed On Alcohol In Pregnancy 2
...eica ASP200 is an advanced smart processor for par...ne histopathology applications. Proven and enhance... smart operating software are the hallmark of the ...ed and the software includes a variety of SMART fe...
The electronic, motorized rotary microtomes are designed for all applications of paraffin, semi-thin (HM 360), and hard specimens in clinical, research, and industrial labs. These instruments display
...eica RM2255 rotary microtome, designed for fully m...bedded specimens, offers a broad application spect...ory. This microtome meets the requirements of user...c microtome for their laboratory. The entire acces...
State-of-the-Art modular embedding station providing performance and ease of use to meet the needs of the most demanding user.
Medicine Products: